Safety and efficacy of undenatured type II collagen in the treatment of osteoarthritis of the knee

A clinical trial

David C. Crowley, Francis C. Lau, Prachi Sharma, Malkanthi Evans, Najla Guthrie, Manashi Bagchi, Debasis Bagchi, Dipak K. Dey, Siba P Raychaudhuri

Research output: Contribution to journalArticle

36 Citations (Scopus)

Abstract

Previous studies have shown that undenatured type II collagen (UC-II) is effective in the treatment of rheumatoid arthritis, and preliminary human and animal trials have shown it to be effective in treating osteoarthritis (OA). The present clinical trial evaluated the safety and efficacy of UC-II as compared to a combination of glucosamine and chondroitin (G+C) in the treatment of OA of the knee. The results indicate that UC-II treatment was more efficacious resulting in a significant reduction in all assessments from the baseline at 90 days; whereas, this effect was not observed in G+C treatment group. Specifically, although both treatments reduced the Western Ontario McMaster Osteoarthritis Index (WOMAC) score, treatment with UC-II reduced the WOMAC score by 33% as compared to 14% in G+C treated group after 90 days. Similar results were obtained for visual analog scale (VAS) scores. Although both the treatments reduced the VAS score, UC-II treatment decreased VAS score by 40% after 90 days as compared to 15.4% in G+C treated group. The Lequesne's functional index was used to determine the effect of different treatments on pain during daily activities. Treatment with UC-II reduced Lequesne's functional index score by 20% as compared to 6% in G+C treated group at the end of 90-day treatment. Thus, UC-II treated subjects showed significant enhancement in daily activities suggesting an improvement in their quality of life.

Original languageEnglish (US)
Pages (from-to)312-321
Number of pages10
JournalInternational Journal of Medical Sciences
Volume6
Issue number6
StatePublished - Oct 9 2009

Fingerprint

Collagen Type II
Knee Osteoarthritis
Clinical Trials
Safety
Visual Analog Scale
Therapeutics
Osteoarthritis
Chondroitin
Glucosamine
Ontario
Rheumatoid Arthritis
Quality of Life

Keywords

  • Chondroitin
  • Glucosamine
  • Lequesne's functional index
  • Osteoarthritis
  • Undenatured type II collagen
  • Visual analog scale
  • WOMAC

ASJC Scopus subject areas

  • Medicine(all)

Cite this

Safety and efficacy of undenatured type II collagen in the treatment of osteoarthritis of the knee : A clinical trial. / Crowley, David C.; Lau, Francis C.; Sharma, Prachi; Evans, Malkanthi; Guthrie, Najla; Bagchi, Manashi; Bagchi, Debasis; Dey, Dipak K.; Raychaudhuri, Siba P.

In: International Journal of Medical Sciences, Vol. 6, No. 6, 09.10.2009, p. 312-321.

Research output: Contribution to journalArticle

Crowley, DC, Lau, FC, Sharma, P, Evans, M, Guthrie, N, Bagchi, M, Bagchi, D, Dey, DK & Raychaudhuri, SP 2009, 'Safety and efficacy of undenatured type II collagen in the treatment of osteoarthritis of the knee: A clinical trial', International Journal of Medical Sciences, vol. 6, no. 6, pp. 312-321.
Crowley, David C. ; Lau, Francis C. ; Sharma, Prachi ; Evans, Malkanthi ; Guthrie, Najla ; Bagchi, Manashi ; Bagchi, Debasis ; Dey, Dipak K. ; Raychaudhuri, Siba P. / Safety and efficacy of undenatured type II collagen in the treatment of osteoarthritis of the knee : A clinical trial. In: International Journal of Medical Sciences. 2009 ; Vol. 6, No. 6. pp. 312-321.
@article{4f2c8b1ee38643388ee4e9d3d6cb8f7f,
title = "Safety and efficacy of undenatured type II collagen in the treatment of osteoarthritis of the knee: A clinical trial",
abstract = "Previous studies have shown that undenatured type II collagen (UC-II) is effective in the treatment of rheumatoid arthritis, and preliminary human and animal trials have shown it to be effective in treating osteoarthritis (OA). The present clinical trial evaluated the safety and efficacy of UC-II as compared to a combination of glucosamine and chondroitin (G+C) in the treatment of OA of the knee. The results indicate that UC-II treatment was more efficacious resulting in a significant reduction in all assessments from the baseline at 90 days; whereas, this effect was not observed in G+C treatment group. Specifically, although both treatments reduced the Western Ontario McMaster Osteoarthritis Index (WOMAC) score, treatment with UC-II reduced the WOMAC score by 33{\%} as compared to 14{\%} in G+C treated group after 90 days. Similar results were obtained for visual analog scale (VAS) scores. Although both the treatments reduced the VAS score, UC-II treatment decreased VAS score by 40{\%} after 90 days as compared to 15.4{\%} in G+C treated group. The Lequesne's functional index was used to determine the effect of different treatments on pain during daily activities. Treatment with UC-II reduced Lequesne's functional index score by 20{\%} as compared to 6{\%} in G+C treated group at the end of 90-day treatment. Thus, UC-II treated subjects showed significant enhancement in daily activities suggesting an improvement in their quality of life.",
keywords = "Chondroitin, Glucosamine, Lequesne's functional index, Osteoarthritis, Undenatured type II collagen, Visual analog scale, WOMAC",
author = "Crowley, {David C.} and Lau, {Francis C.} and Prachi Sharma and Malkanthi Evans and Najla Guthrie and Manashi Bagchi and Debasis Bagchi and Dey, {Dipak K.} and Raychaudhuri, {Siba P}",
year = "2009",
month = "10",
day = "9",
language = "English (US)",
volume = "6",
pages = "312--321",
journal = "International Journal of Medical Sciences",
issn = "1449-1907",
publisher = "Ivyspring International Publisher",
number = "6",

}

TY - JOUR

T1 - Safety and efficacy of undenatured type II collagen in the treatment of osteoarthritis of the knee

T2 - A clinical trial

AU - Crowley, David C.

AU - Lau, Francis C.

AU - Sharma, Prachi

AU - Evans, Malkanthi

AU - Guthrie, Najla

AU - Bagchi, Manashi

AU - Bagchi, Debasis

AU - Dey, Dipak K.

AU - Raychaudhuri, Siba P

PY - 2009/10/9

Y1 - 2009/10/9

N2 - Previous studies have shown that undenatured type II collagen (UC-II) is effective in the treatment of rheumatoid arthritis, and preliminary human and animal trials have shown it to be effective in treating osteoarthritis (OA). The present clinical trial evaluated the safety and efficacy of UC-II as compared to a combination of glucosamine and chondroitin (G+C) in the treatment of OA of the knee. The results indicate that UC-II treatment was more efficacious resulting in a significant reduction in all assessments from the baseline at 90 days; whereas, this effect was not observed in G+C treatment group. Specifically, although both treatments reduced the Western Ontario McMaster Osteoarthritis Index (WOMAC) score, treatment with UC-II reduced the WOMAC score by 33% as compared to 14% in G+C treated group after 90 days. Similar results were obtained for visual analog scale (VAS) scores. Although both the treatments reduced the VAS score, UC-II treatment decreased VAS score by 40% after 90 days as compared to 15.4% in G+C treated group. The Lequesne's functional index was used to determine the effect of different treatments on pain during daily activities. Treatment with UC-II reduced Lequesne's functional index score by 20% as compared to 6% in G+C treated group at the end of 90-day treatment. Thus, UC-II treated subjects showed significant enhancement in daily activities suggesting an improvement in their quality of life.

AB - Previous studies have shown that undenatured type II collagen (UC-II) is effective in the treatment of rheumatoid arthritis, and preliminary human and animal trials have shown it to be effective in treating osteoarthritis (OA). The present clinical trial evaluated the safety and efficacy of UC-II as compared to a combination of glucosamine and chondroitin (G+C) in the treatment of OA of the knee. The results indicate that UC-II treatment was more efficacious resulting in a significant reduction in all assessments from the baseline at 90 days; whereas, this effect was not observed in G+C treatment group. Specifically, although both treatments reduced the Western Ontario McMaster Osteoarthritis Index (WOMAC) score, treatment with UC-II reduced the WOMAC score by 33% as compared to 14% in G+C treated group after 90 days. Similar results were obtained for visual analog scale (VAS) scores. Although both the treatments reduced the VAS score, UC-II treatment decreased VAS score by 40% after 90 days as compared to 15.4% in G+C treated group. The Lequesne's functional index was used to determine the effect of different treatments on pain during daily activities. Treatment with UC-II reduced Lequesne's functional index score by 20% as compared to 6% in G+C treated group at the end of 90-day treatment. Thus, UC-II treated subjects showed significant enhancement in daily activities suggesting an improvement in their quality of life.

KW - Chondroitin

KW - Glucosamine

KW - Lequesne's functional index

KW - Osteoarthritis

KW - Undenatured type II collagen

KW - Visual analog scale

KW - WOMAC

UR - http://www.scopus.com/inward/record.url?scp=74549119454&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=74549119454&partnerID=8YFLogxK

M3 - Article

VL - 6

SP - 312

EP - 321

JO - International Journal of Medical Sciences

JF - International Journal of Medical Sciences

SN - 1449-1907

IS - 6

ER -